ST3GAL5 overexpression was identified to successfully predict poor prognosis and CD8+ T cell exhaustion in ccRCC, which was further validated in our own cohort using immunohistochemistry and immunofluorescence staining methods. The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.